GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+98.85%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$370M
AUM Growth
+$370M
(+29%)
Cap. Flow
-$62.6M
Cap. Flow
% of AUM
-16.9%
Top 10 Holdings %
Top 10 Hldgs %
49.75%
Holding
62
New
19
Increased
13
Reduced
12
Closed
13
Top Buys
| 1 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$27.1M |
| 2 |
Immunovant
IMVT
|
$12.7M |
| 3 |
Aurinia Pharmaceuticals
AUPH
|
$12.2M |
| 4 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$8.46M |
| 5 |
DBVT
DBV Technologies
DBVT
|
$8.03M |
Top Sells
| 1 |
Axsome Therapeutics
AXSM
|
$49.1M |
| 2 |
Sarepta Therapeutics
SRPT
|
$20M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$16.9M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$16.1M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$15.4M |
Sector Composition
| 1 | Healthcare | 90.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
51
DELISTED
Sage Therapeutics
SAGE
| – | – |
-110,000
| Closed | -$15.4M |
|
52
Solid Biosciences
SLDB
$442M
| – | – |
-100,000
| Closed | -$1.03M |
|
53
SPDR S&P 500 ETF Trust
SPY
$655B
| – | – |
0
| – | – |
|
54
SPDR S&P Biotech ETF
XBI
$5.26B
| – | – |
0
| – | – |
|
55
Q32 Bio
QTTB
$20.9M
| – | – |
-225,000
| Closed | -$4.07M |
|
|
TECX
56
Tectonic Therapeutic, Inc. Common Stock
TECX
$312M
| – | – |
-155,253
| Closed | -$2.19M |
|
|
CBAY
57
DELISTED
Cymabay Therapeutics
CBAY
| – | – |
-440,000
| Closed | -$2.25M |
|
|
ATNX
58
DELISTED
Athenex, Inc. Common Stock
ATNX
| – | – |
-522,500
| Closed | -$6.36M |
|
|
TPTX
59
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| – | – |
-125,000
| Closed | -$4.7M |
|
|
EPZM
60
DELISTED
Epizyme, Inc
EPZM
| – | – |
-132,000
| Closed | -$1.36M |
|
|
DRNA
61
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| – | – |
-235,000
| Closed | -$3.38M |
|
|
DERM
62
DELISTED
Dermira, Inc.
DERM
| – | – |
-42,500
| Closed | -$272K |
|